Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase I trial evaluates IBS therapy SMP-100 in healthy volunteers

July 30, 2020

Enterome begins clinical evaluation of cancer multipeptide therapeutic vaccine EO-2401

July 30, 2020

Constant Therapeutics initiates phase II study of TXA-127 for COVID-19

July 30, 2020

First patient dosed in phase I/II study of RP-3500

July 30, 2020

Arrowhead initiates phase II study of AMG-890

July 30, 2020

Apogenix receives regulatory approval in Russia for phase II study of asunercept in COVID-19

July 30, 2020

Positive topline data presented from phase IIa ACTION study of DMX-200 in FSGS

July 30, 2020

Screening in serum yields potential antibiotics against drug-resistant K. pneumoniae

July 30, 2020

Astrogen identifies new serine derivatives

July 30, 2020

Genetic variant combination in MPIG6B and SH2B3 genes leads to myelofibrosis and thrombocytopenia

July 30, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...